CSE’s White Paper on Promoting Integrity in Scientific Journal Publications, 2012 Update
(approved by the CSE Board of Directors on March 30, 2012)
Download a PDF of the entire White Paper
2.0 ROLES AND RESPONSIBILITIES IN PUBLISHING
2.1.1 Editorial Freedom
2.1.3 Conflicts of Interest
2.1.4 Conflict of Interest Disclosure
2.1.5 Citation Manipulation
2.1.6 Editorial Board Participation
2.1.7 Timeliness of the Publication Process
2.1.8 Errata, Retractions, and Expressions of Concern
2.1.9 Addressing Authorship Disputes
2.1.10 Considering Appeals for Reconsideration of Rejected Manuscripts
2.1.11 Addressing Allegations or Findings of Misconduct (see section 3.0)
2.1.13 Resources and Case Studies
2.2.2 Contributorship Models
2.2.4 Order of Authors
2.2.5 Changes to the Author Byline
2.2.6 Author Responsibilities
2.2.8 Resources and Case Studies
2.3.1 Reviewer Selection
2.3.2 Ethical Responsibilities of Reviewers
2.3.3 Examples of Reviewer Impropriety
2.3.4 Using Anonymous Reviewers: Critique of the Process
2.3.5 Rewarding Reviewers
2.3.7 Resources and Case Studies
188.8.131.52 Publication Planning
184.108.40.206 Process Control (Content and Journal Selection)
220.127.116.11 Disclosure of Conflicts of Interest
18.104.22.168 Access to and Provision of Data
22.214.171.124 Clinical Trial Registration and Dissemination of Findings
3.0 IDENTIFICATION OF RESEARCH MISCONDUCT AND GUIDELINES FOR ACTION
3.3.1 Why Might a Manuscript be Considered Suspect?
3.3.2 Who Might Notify a Journal about a Suspect Manuscript?
3.3.3 What Should be Done When Misconduct is Alleged?
3.3.4 Whom Should a Journal Notify about a Suspect Manuscript?
3.3.5 What to do if the Submitting Author’s Response is not Satisfactory
3.3.6 Who Investigates Allegations of Misconduct?
3.3.7 What Information Should be Provided During Investigations?
3.3.8 Handling Accusations from Anonymous Sources